Month: January 2022

CENTREVILLE, Va., Jan. 19, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) today announced that the company was awarded a task order to provide testing solutions in response to the COVID-19 pandemic at the U.S. Department of Homeland Security (DHS) Immigration and Customs Enforcement (ICE) facilities across the United States. The award includes a one-year base and two one-year option periods, for a potential total value, including surge capacity, of more than $100 million. This task order was issued under the DHS COVID-19 Testing Solutions IDIQ, on which Parsons was awarded a contract in November of 2020. Parsons will supply best-in-class, emergency use authorized, portable, rapid molecular and rapid antigen test kits to DHS, as well as provide logistics, coordination, and training support as part of this important testing...

Los Angeles, CA., Jan. 19, 2022 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce a partnership with Women And Drones, the premier global platform for women who are disrupting, innovating and shaping the future of STEM and aviation.  Women And Drones is the leading membership organization dedicated to driving excellence in the uncrewed aircraft systems (UAS) and Advance Air Mobility (AAM) industry by advocating for female participation in this dynamic segment of the global economy. From 2018 to 2021, the organization has been named one of the top companies to watch in the UAS industry. Women And Drones’ educational programs range from kindergarten to career in an effort to balance...

Special Meeting Scheduled for February 15, 2022The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTSNEW YORK, New York and JERUSALEM, Israel, Jan. 19, 2022 (GLOBE NEWSWIRE) — Healthcare Capital Corp (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) today announced that on January 12, 2022, the U.S. Securities and Exchange Commission (“SEC”) declared effective the Registration Statement on Form F-4 (as amended, the “Registration Statement”) filed by Alpha Tau Medical Ltd. (“Alpha Tau”), which includes a definitive proxy statement/prospectus in connection with HCCC’s special meeting of stockholders (the “Special Meeting”). At the Special Meeting, stockholders of HCCC will consider the previously announced proposed business combination (the “Business Combination”) with Alpha Tau, an...

Location of Drill HolesLocation of Drill HolesCross SectionCross SectionTORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) — (“Denarius” or the “Company”) (TSXV: DSLV) is pleased to announce that it has received complete assays for the first four drill holes from the ongoing surface diamond drilling program on its 100%-owned polymetallic Lomero-Poyatos Project. This is the Company’s first diamond drill campaign at its flagship project in Andalucia Region, Southern Spain, located within the Iberian Pyrite Belt. The Lomero-Poyatos Project comprises a 100% interest in the P.I. Rubia, License Nº 14.977, covering the areas occupied by the former Lomero-Poyatos Concessions. Additional assays are expected in the coming weeks and it is expected there should be a steady flow of new assay data as drill holes are completed...

ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg offentliggør hermed finanskalender 2022 for Værdipapirfonden Sparindex: Fredag den 25. marts 2022        Offentliggørelse af årsrapport 2021Fredag den 26. august 2022       Offentliggørelse af halvårsrapport 2022 Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til filialbestyrer Thomas Valentiner, tlf.nr. 36 34 70 52. Med venlig hilsen Thomas Valentiner Filialbestyrer, ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg

TORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the fourth quarter ended December 31, 2021 by press release on Tuesday, February 15, 2022 at approximately 7:30 am ET. The conference call to review these financial results will take place at 11:00 am ET on Tuesday, February 15, 2022, and will be hosted by D. Scott Patterson, CEO, and Jeremy Rakusin, CFO. The numbers to use for this call are 1) toll-free 1-888-241-0551; or 2) for international callers, 647-427-3415. The conference call will also be accessible on our website at www.firstservice.com in the “Investors” section under the tab “Newsroom”. For anyone unable to listen to the scheduled call, the rebroadcast number will be 1-855-859-2056 with the conference...

Confidence in the Success and Positive Impact of Blockchain and Cryptocurrency Drives Technology Toward Mainstream Adoption WASHINGTON, Jan. 19, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced its Technology segment’s report on the state of blockchain technology and cryptocurrency adoption in fintech and financial services. Based on an in-depth survey of decision makers at organizations with an average annual revenue of $11.6 billion, The State of Blockchain Technology and Digital Assets in Financial Services: A Benchmark on the Disruption of an Industry, revealed that investment in blockchain technology or cryptocurrencies will be a high or significant priority over the next 12 months. Respondents indicated they are spending an average of $176.4 million per year on these projects, and plan to increase...

CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCV Expands the Company’s rare cannabinoid product portfolio, which also includes cannabichromene (CBC) Strengthens leadership position in commercial scale production of high demand rare cannabinoidsVANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce it has launched B2B sales of the rare cannabinoid cannabicitran (CBT) into the health and wellness sector. CBT is the first of several new product launches planned for the first half of 2022. InMed’s subsidiary, BayMedica, has received initial purchase orders and has commenced...

Figure 1Plan View of Holes 08-35, 11-44, 12-47, 48, 49, 50A, 50W2, 21-58 & 21-60A Showing Potential Extension of EndoskarnFigure 2View to Northwest of Key Results Hole 21-60AFigure 3Oblique View to the North of the Endoskarn Zone with Key Results Hole 21-60AFigure 4Oblique View to the Northwest of the Endoskarn Zone with Key Results Hole 21-60ATORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) — Golden Tag Resources Ltd. (“Golden Tag” or the “Company“) (TSX.V: GOG) (OTCQB: GTAGF) is pleased to announce complete results from diamond drillhole 21-60A, part of an exploration program targeting bulk-tonnage mineralization on the Company’s 100% owned San Diego Project, located in Durango Mexico. Key highlights from hole 21-60A include:272 g/t Ag.Eq over 7.8...

BOSTON, Jan. 19, 2022 (GLOBE NEWSWIRE) — Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative disease, today announced that, in response to its IND application submitted in December 2021, it was notified via email by the U.S. Food and Drug Administration (FDA) that the FDA has placed a partial clinical hold on multidose clinical trials of YTX-7739, currently being developed for the treatment of Parkinson’s disease. The FDA has not halted all clinical programming and is permitting the Company’s planned single dose clinical trial to proceed. The partial clinical hold suspends initiation of multiple dose clinical trials in the U.S. until the FDA’s questions have been addressed. The Company expects to...